echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Diabetes Care: Analysis of Type 1 Diabetes Hospitalized by COVID-19 in Intensive Care Unit, Mechanical Ventilation and Mortality

    Diabetes Care: Analysis of Type 1 Diabetes Hospitalized by COVID-19 in Intensive Care Unit, Mechanical Ventilation and Mortality

    • Last Update: 2021-07-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A research article published in Diabetes Care, an authoritative journal in the field of diabetes , aims to assess whether patients with type 1 diabetes (T1DM) hospitalized due to COVID-19 and patients without diabetes or type 2 diabetes (T2DM) have different risks of serious outcomes .

    Diabetes COVID-19 Type 1 Diabetes

    The researchers used the COVID-19 database to collect data on patients hospitalized with COVID-19 in U.


    S.


    Compared with non-diabetic patients, the absolute risk of ICU/MV in T1DM patients is increased by 21% (RD is 0.
    21, 95% CI is 0.
    19-0.
    24; RR is 1.
    49, 95% CI is 1.
    43-1.
    56), and the absolute risk of death is increased by 5% (RD is 0.
    05, 95%CI is 0.
    03-0.
    07; RR is 1.
    40, 95%CI is 1.
    24-1.
    57), and adjusted according to age, gender and race or ethnicity
    .

    Comparison of main endings

    Compared with T2DM, the absolute risk of ICU/MV in T1DM patients increased by 9% (RD of 0.
    09, 95% CI of 0.
    07-0.
    12; RR of 1.
    17, 95% CI of 1.
    12-1.
    22), but there was no difference in mortality (RD Is 0.
    00, 95%CI is -0.
    02 to 0.
    02; RR is 1.
    00, 95%CI is 0.
    89-1.
    13)
    .


    After adjusting for diabetic ketoacidosis (DKA) that occurred before or at the time of diagnosis of COVID-19 , compared with T2DM patients, the ICU/MV risk of T1DM patients no longer increased (RD is 0.


    diagnosis

    It can be seen that T1DM patients hospitalized with COVID-19 are at higher risk of severe outcomes than non-diabetic patients
    .


    The main reason why the ICU/MV risk of T1DM patients is higher than that of T2DM patients is that they are accompanied by DKA


    T1DM patients hospitalized with COVID-19 are at higher risk of severe outcomes than non-diabetic patients
    .
    The main reason why the ICU/MV risk of T1DM patients is higher than that of T2DM patients is that they are accompanied by DKA
    .
    These results further guidance COVID-19 diabetes treatment and prevention preventive original source: Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in at The US in this message
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.